ArticleJournal of orthopaedic surgery and research2026
Platelet-rich plasma facilitates earlier functional recovery and return to sport in traumatic meniscal repair: a retrospective cohort study.
Article in Journal of orthopaedic surgery and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate the clinical efficacy of arthroscopic repair combined with platelet-rich plasma (PRP) injection for traumatic meniscal tears.
methodsA retrospective cohort study included patients who underwent arthroscopic repair for traumatic meniscal tears between January 2023 and August 2024. Clinical outcomes were evaluated preoperatively and at 6 and 12 months postoperatively using the International Knee Documentation Committee (IKDC) score, Tegner activity scale (Tegner scale), and visual analogue scale (VAS). MRI healing rate, return to sport (RTS) outcomes, and postoperative satisfaction were evaluated. Subgroup analyses were conducted for patients with preoperative bone marrow edema (BME).
resultsA total of 96 patients were included (48 per group), with comparable baseline characteristics. At 6 months, the PRP group demonstrated significantly greater improvements in IKDC score, Tegner scale and VAS than the surgery-alone group (p < 0.001, p = 0.036, and p < 0.001, respectively), with differences exceeding the minimal clinically important differences (MCIDs). MRI healing rate was higher in the PRP group (p = 0.014). By 12 months, improvements in IKDC score and VAS remained superior in the PRP group though differences no longer exceeded MCIDs. Tegner scale and MRI healing rates were comparable (p = 0.265 and 0.088, respectively). The PRP group achieved superior RTS outcomes. Satisfaction (≥ satisfied) was high in both groups (95.8% vs. 89.6%). In the PRP group, postoperative IKDC scores did not differ significantly between patients with and without BME, whereas in the surgery-alone group, scores were significantly lower in those with BME.
conclusionsPRP augmentation for traumatic meniscal repair may provide clinically improvements at 6 months postoperatively, including better IKDC score, Tegner scale, and VAS, a higher meniscal healing rate, and facilitate earlier RTS. However, these benefits diminished by 12 months, with functional differences falling below the MCID and no sustained difference in healing rate. Patients with preoperative BME may derive greater functional benefit from adjunctive PRP treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.